Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a ...

The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in hepatocellular carcinoma patients. Median progression-free survival was 8.3 months with ...

Survival rates for patients with hepatocellular carcinoma (HCC) have improved, but overall survival remains low. Early detection and treatment significantly enhanced survival outcomes between January ...

According to a recent systematic review published in JCO Oncology Practice, implementation of same-day multidisciplinary ...

Orphan Drug Designation is a key incentive established by the EMA to facilitate the development and authorisation of ...

Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide. If you have the appropriate software installed, you can download article citation data to the citation manager of your ...